A unique serine-rich repeat protein (Srr-2) and novel surface antigen (ε) associated with a virulent lineage of serotype III Streptococcus agalactiae

Microbiology

Volumn 152, Issue 4, 2006, Pages 1029-1040

  Seifert, Kyle N ^a   Adderson, Elisabeth E ^b   Whiting, April A ^c   Bohnsack, John F ^c   Crowley, Paula J ^d   Brady, L Jeannine ^d  

^a JAMES MADISON UNIVERSITY   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; MEMBRANE ANTIGEN; PROTEIN ANTIBODY; SERINE RICH REPEAT PROTEIN 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE LOCUS; IN VIVO STUDY; MOLECULAR WEIGHT; MOUSE; NEWBORN; NEWBORN INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY; SEROTYPE; STAPHYLOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; DNA FINGERPRINTING; DNA, BACTERIAL; HUMANS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; STAPHYLOCOCCUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; SURVIVAL ANALYSIS; VIRULENCE FACTORS;

ANIMALIA; BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 33645545315     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.28516-0     Document Type: Article

References (62)

1. Adderson, E. E., Takahashi, S., Wang, Y., Armstrong, J., Miller, D. V. & Bohnsack, J. F. (2003). Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae. Infect Immun 71, 6857-6863.
2. Areschoug, T., Stalhammar-Carlemalm, M., Karlsson, I. & Lindahl, G. (2002). Streptococcal beta protein has separate binding sites for human factor H and IgA-Fc. J Biol Chem 277, 12642-12648.
3. Auperin, T. C., Bolduc G. R., Baron, M. J., Heroux, A., Filman, D. J., Madoff, L. C. & Hogle, J. M. (2005). Crystal structure of the N-terminal domain of the group B Streptococcus alpha C protein. J Biol Chem 280, 18245-18252.
4. Baker, C. J. & Edwards, M. S. (2001). Group B streptococcal infections. In Infectious Diseases of the Fetus and Newborn Infant, pp. 1091-1156. Edited by J. S. Remington & J. O. Klein. Philadelphia, PA: W. B. Saunders.
5. Bensing, B. A. & Sullam, P. M. (2002). An accessory sec locus of Streptococcus gordonii is required for export of the surface protein GspB and for normal levels of binding to human platelets. Mol Microbiol 44, 1081-1094.
6. Bensing, B. A., Lopez J. A. & Sullam, P. M. (2004). The Streptococcus gordonii surface proteins GspB and Hsa mediate binding to sialylated carbohydrate epitopes on the platelet membrane glycoprotein lbalpha. Infect Immun 72, 6528-6537.
7. Bevanger, L. (1985). The Ibc proteins of group B streptococci: isolation of the alpha and beta antigens by immunosorbent chromatography and test for human serum antibodies against the two antigens. Acta Pathol Microbiol Immunol Scand Sect B Microbiol 93, 113-119.
8. Bisharat, N., Crook D. W., Leigh, J., Harding, R. M., Ward, P. N., Coffey, T. J., Maiden, M. C., Peto, T. & Jones, N. (2004). Hyper-invasive neonatal group B streptococcus has arisen from a bovine ancestor. J Clin Microbiol 42, 2161-2167.
9. Bohnsack, J. F., Takahashi, S., Detrick S. R., Pelinka, L. R., Hammitt L. L., Aly, A. A., Whiting, A. A. & Adderson, E. E. (2001). Phylogenetic classification of serotype III group B streptococci on the basis of hylB gene analysis and DNA sequences specific to restriction digest pattern type III-3. J Infect Dis 183, 1694-1697.
10. Bohnsack, J. F., Whiting, A. A., Bradford, R. D., Van Frank, B. K., Takahashi, S. & Adderson, E. E. (2002). Long-range mapping of the Streptococcus agalactiae phylogenetic lineage restriction digest pattern type III-3 reveals clustering of virulence genes. Infect Immun 70, 134-139.
11. Boyer, K. M., Gadzala, C. A., Kelly, P. D., Burd, L. I. & Gotoff, S. P. (1983). Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. I Infect Dis 148, 802-809.
12. Brady, L. J., Daphtary, U. D., Ayoub, E. M. & Boyle, M. D. (1988). Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay. J Infect Dis 158, 965-972.
13. Brady, L. J., Hofig, A., Addison, M. N. & Lim, D. V. (1996). Association of two antigens, delta and epsilon, with pathogenic serotype III group B streptococci. Proceedings of the 96th General Meeting of the American Society for Microbiology, abstract no. B-350. Washington, DC: American Society for Microbiology.
14. Chen, Q., Wu, H. & Fives-Taylor, P. M. (2002). Construction of a novel transposon mutagenesis system useful in the isolation of Streptococcus parasanguis mutants defective in Fapl glycosylation. Infect Immun 70, 6534-6540.
15. Chun, C. S., Brady, L. J., Boyle, M. D., Dillon, H. C. & Ayoub, E. M. (1991). Group B streptococcal C protein-associated antigens: association with neonatal sepsis. J Infect Dis 163, 786-791.
16. Cleat P. H. & Timmis, K. N. (1987). Cloning and expression in Escherichia coli of the Ibc protein genes of group B streptococci: binding of human immunoglobulin A to the beta antigen. Infect Immun 55, 1151-1155.
17. Davies, H. D., Jones, N., Whittam, T. S., Elsayed, S., Bisharat N. & Baker, C. J. (2004). Multilocus sequence typing of serotype III streptococcus and correlation with pathogenic potential. J Infect Dis 189, 1097-1102.
18. Farley, M. M. (2001). Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 33, 556-561.
19. Ferrieri, P. (1985). GBS infections in the newborn infant: diagnosis and treatment. Antibiot Chemother 35, 211-224.
20. Fischetti, V. A., Pancholi, V. & Schneewind, O. (1990). Conservation of a hexapeptide sequence in the anchor region of surface proteins from gram-positive cocci. Mot Microbiol 4, 1603-1605.
21. Fleming, K. E., Bohnsack, J. F., Palacios, G. C., Takahashi, S. & Adderson, E. E. (2004). Equivalence of high-virulence clonotypes of serotype III group B Streptococcus agalactiae (GBS). J Med Microbiol 53, 505-508.
22. Glaser, P., Rusniok, C., Buchrieser, C. & 9 other authors (2002). Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mot Microbiol 45, 1499-1513.
23. Gravekamp, C., Horensky, D. S., Michel, J. L. & Medoff, L. C. (1996). Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes. Infect Immun 64, 3576-3583.
24. Handley, P. S., Correia, F. F., Russell, V., Rosen, B. & DiRienzo, J. M. (2005). Association of a novel high molecular weight, serine-rich protein (SrpA) with fibril-mediated adhesion of the oral biofilm. bacterium Streptococcus cristatus. Oral Microbiol Immunol 20, 131-140.
25. Héry-Arnaud, G., Bruant, G., Lanotte, P., Brun, S., Rosenau, A., van der Mee-Marquet N., Quentin, R. & Mereghetti, L. (2005). Acquisition of insertion sequences and the GBSil intron by Streptococcus agalactiae isolates correlates with the evolution of the species. J Bacteriol 187, 6248-6252.
26. Johnson, D. R. & Ferrieri, P. (1984). Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol 19, 506-510.
27. Jones, N., Bohnsack, J. F., Takahashi, S. & 9 other authors (2003). Multilocus sequence typing for group B streptococcus. J Clin Microbiol 41, 2530-2536.
28. Kremer, B. H., van der Kraan, M., Crowley, P. J., Hamilton, I. R., Brady, L. J. & Bleiweis, A. S. (2001). Characterization of the sat operon in Streptococcus mutans: evidence for a role of Ffh in add tolerance. J Bacteriol 183, 2543-2552.
29. Law, M. R., Palomaki, G., Alfirevic, Z., Gilbert P., Heath, P., McCartney, C., Reid, T. & Schrag, S. (2005). The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. J Med Screen 12, 60-68.
30. Lindahl, G., Stalhammar-Carlemalm, M. & Areschoug, T. (2005). Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev 18, 102-127.
31. Luan, S. L., Granlund, M., Sellin, M., Lagergard, T., Spratt, B. G. & Norgren, M. (2005). Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol 43, 3727-3733.
32. Maeland, J. A., Brakstad, O. G., Bevanger, L. & Kvam, A. I. (1997). Streptococcus agalactiae beta gene and gene product variations. J Med Microbiol 46, 999-1005.
33. Maione, D., Margarit, I., Rinaudo, C. D. & 24 other authors (2005). Identification of a universal Group B Streptococcus vaccine by multiple genome screen. Science 309, 148-150.
34. Martin, T. R., Rubens, C. E. & Wilson, C. B. (1988). Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J Infect Dis 157, 91-100.
35. Michel, J. L., Madoff, L. C., Kling, D. E., Kasper, D. L. & Ausubel, F. M. (1991). Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect Immun 59, 2023-2028.
36. Michon, F., Brisson, J. R., Dell, A., Kasper, D. L. & Jennings, H. J. (1988). Multiantennary group-specific polysaccharide of group B Streptococcus. Biochemistry 27, 5341-5351.
37. Musser, J. M., Mattingly, S. J, Quentin, R., Goudeau, A., & Selander, R. K. (1989). Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci U S A 86, 4731-4735.
38. Nagano, Y., Nagano, N., Takahashi, S., Murono, K., Fujita, K., Taguchi, F. & Okuwaki, Y. (1991). Restriction endonuclease digest patterns of chromosomal DNA from group B beta-haemolytic streptococci. J Med Microbiol 35, 297-303.
39. Puopolo, K. M., Madoff, L. C. & Elchenwaid, E. C. (2005). Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115, 1240-1246.
40. Reed, L. J. & Muench, M. H. (1938). A simple method of estimating fifty per cent endpoints. Am J Hyg 27, 493-497.
41. Rodewald, A. K., Onderdonk, A. B., Warren, H. B. & Kasper, D. L. (1992). Neonatal mouse model of group B streptococcal infection. J Infect Dis 166, 635-639.
42. Rubens, C. E. & Heggen, L. (1988). Tn916ΔE: a Tn916 derivative expressing erythromycin resistance. Plasmid 20, 137-142.
43. Russell-Jones, G. J. & Gotschlich, E. C. (1984). Identification of protein antigens of group B streptococci, with special reference to the Ibc antigens. J Exp Med 160, 1476-1484.
44. Sambrook J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
45. Schrag, S. J., Zywicki, S., Farley, M. M. & 7 other authors (2000). Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342, 15-20.
46. Seifert K. N., McArthur, W. P., Blelwels, A. S. & Brady, L. J. (2003). Characterization of group B streptococcal glyceraldehyde-3-phosphate dehydrogenase: surface localization, enzymatic activity, and protein-protein interactions. Can I Microbiol 49, 350-356.
47. Siboo, I. R., Chambers, H. F. & Sullam, P. M. (2005). Role of SraP, a serine-rich surface protein of Staphylococcus aureus, in binding to human platelets. Infect Immun 73, 2273-2280.
48. Staden, R. (1996). The Staden sequence analysis package. Mol Biotechnol 5, 233-241.
49. Stalhammar-Carlemalm, M., Stenberg, L. & Lindahl, G. (1993). Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med 177, 1593-1603.
50. Stephenson, A. E., Wu, H., Novak J., Tomana, M., Mintz, K. & Fives-Taylor, P. (2002). The Fap1 fimbrial adhesin is a glycoprotein: antibodies specific for the glycan moiety block the adhesion of Streptococcus parasanguis in an in vitro tooth model. Mol Microbiol 43, 147-157.
51. Takahashi, S., Adderson, E. E., Nagano, Y., Nagano, N., Briesacher, M. R. & Bohnsack, J. F. (1998). Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci. J Infect Dis 177, 1116-1119.
52. Takahashi, Y., Konishi, K., Cisar, J. O. & Yoshikawa, M. (2002). Identification and characterization of hsa, the gene encoding the sialic acid-binding adhesin of Streptococcus gordonii DL1. Infect Immun 70, 1209-1218.
53. Takahashi, Y., Yajima, A., Cisar, J. O. & Konishi, K. (2004). Functional analysis of the Streptococcus gordonii DL1 sialic acid-binding adhesin and its essential role in bacterial binding to platelets. Infect Immun 72, 3876-3882.
54. Takamatsu, D., Bensing, B. A. & Sullam, P. M. (2004a). Four proteins encoded in the gspB-secY2A2 operon of Streptococcus gordonii mediate the intracellular glycosylation of the platelet-binding protein GspB. J Bacteriol 186, 7100-7111.
55. Takamatsu, D., Bensing, B. A. & Sullam, P. M. (2004b). Genes in the accessory sec locus of Streptococcus gordonii have three functionally distinct effects on the expression of the platelet-binding protein GspB. Mol Microbiol 52, 189-203.
56. Tettelin, H., Masignani, V., Cieslewicz, M. J. & 40 other authors (2002). Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A 99, 12391-12396.
57. Tettelin, H. Masignani, V., Clesiewlez, M. J. & 43 other authors (2005). Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc Natl Acad Sci U S A 102, 13950-13955.
58. Tyrrell, G. J., Senzilet, L. D., Spika, J. S. Kertesz, D. A., Alagaratnam, M., Lovgren, M. & Talbot J. A. (2000). Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study - 1996. Sentinel Health Unit Surveillance System Site Coordinators. J Infect Dis 182, 168-173.
59. Ustinovitch, I., Vlasov, G., Totolyan, A. & Suvorov, A. (1999). Cloning and expression of gene fragment IgA-binding protein of group B streptococci. Folia Microbiol (Praha) 44, 726-728.
60. Wilkinson, H. W. & Eagon, R. G. (1971). Type-specific antigens of group B type Ic streptococci. Infect Immun 4, 596-604.
61. Wu, H. & Fives-Taylor, P. M. (1999). Identification of dipeptide repeats and a cell wall sorting signal in the fimbriae-associated adhesin, Fap1, of Streptococcus parasanguis. Mol Microbiol 34, 1070-1081.
62. Wu, H., Mintz, K. P., Ladha, M. & Fives-Taylor, P. M. (1998). Isolation and characterization of Fap1, a fimbriae-associated adhesin of Streptococcus parasanguis FW213. Mol Microbiol 28, 487-500.